The IASLC grading system for invasive pulmonary adenocarcinoma: a potential prognosticator for patients receiving neoadjuvant therapy.

Haoran EJunqi WuYijiu RenLang XiaLong XuShaoling LiYue ZhaoChongwu LiYunlang SheChunxia SuChunyan WuLikun HouDeping ZhaoChang Chen

Published in: Therapeutic advances in medical oncology (2023)

The prognostic efficacy of pathological evaluation of the residual proportion of pulmonary adenocarcinoma post-neoadjuvant therapy using IASLC grading system was preliminarily verified. Such grading system might assist prognostic evaluation of neoadjuvant cohort other than traditional pathological parameters.

Keyphrases

locally advanced
rectal cancer
lymph node
squamous cell carcinoma
pulmonary hypertension
radiation therapy
stem cells
risk assessment
bone marrow